Intellectual Property and Development: Understanding the Interfaces: Liber amicorum Pedro Roffe

This book comprises chapters by leading international authors analysing the interface between intellectual property and foreign direct investment, development, and free trade. The authors search for a balance between the conflicting interests that inherently coexist in intellectual property law.

The chapters dig deep into the subjects and notions that have become central in international intellectual property legal developments: i) flexibility, public interest and policy-space for implementation; ii) interfaces between the intellectual property regime and other legal regimes; and iii) the development of international intellectual property law and its influence on national legal orders, which includes the implementation of intellectual property undertakings.

Carlos Maria Correa is Professor and Director of the Center for Interdisciplinary Studies on Industrial Property and Economics of the University of Buenos Aires. He is Special Advisor on Trade and Intellectual Property of the South Centre, an intergovernmental organization located in Geneva, and has been a visiting professor in post-graduate courses of numerous universities and other regional and international organizations. He has advised several governments on intellectual property, innovation policy and public health.

Xavier Seuba is Senior Lecturer at the Centre d’Études Internationales de la Propriété Intellectuelle (CEIPI) of the University of Strasbourg. He is Academic Coordinator and Judicial Training Manager, and Coordinator of the CEIPI-BETA Project on the law and economics of intellectual property. He teaches courses in various European and American universities in the areas of international intellectual property law, international health law, and international economic law. His research is focused on intellectual property enforcement, intellectual property and health, innovation, and economics of intellectual property. He has advised national governments on intellectual property and pharmaceuticals legislation.